regenHU — a three dimensional biotechnology company, exploiting the potential of 3D bioprinting & cell based therapies — is leading the development of biomedical products for regenerative medicine & drug discovery. Based in Fribourg, Switzerland, regenHU is a pioneer and global leader in the field, converging digital manufacturing (3D printing), biomaterials and biotechnology to lead transformational innovations in Healthcare.
Since 2007, regenHU has dedicated its engineering skills to assisting the scientific community with their cutting-edge bioprinting solutions. Benefiting from a unique network of global partnerships with leading scientific innovators and industrial players, we are constantly at the forefront of innovation.
Value Proposition
regenHU provides leading-edge 3D bioprinting solutions. R&D teams worldwide purchase regenHU’s bioprinting platforms and biomaterials because they provide the greatest flexibility and precision for tissue engineering.